Account
Case Studies

Development and refinement of payer value messages for a novel urology treatment

26/04/2023

Author:

Sarah Bailey
About the Author

Article Tags

Early Payer Dialogue HTA HTA Process Launch Pricing

Share this article

Related articles

Articles
16.06.2025
HST or STA? Navigating NICE’s Dual Pathways for ...

When bringing a new health technology to market in England, pharmaceutical and biotech companies mus...

Read more
Articles
09.06.2025
Early Advice, Long-Term Value: How HTA Engagement ...

The key to pricing success for any pharmaceutical product is effectively exhibiting the asset’...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch